Lake Street Capital started coverage on shares of EnteroMedics (NASDAQ:ETRM) in a research report released on Tuesday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $3.00 price objective on the stock.
Shares of EnteroMedics (NASDAQ:ETRM) traded down 3.27% on Tuesday, hitting $1.48. 284,868 shares of the company’s stock traded hands. EnteroMedics has a one year low of $0.81 and a one year high of $3.53. The stock’s 50-day moving average is $1.21 and its 200-day moving average is $1.08. The company’s market cap is $82.3 million.
EnteroMedics (NASDAQ:ETRM) last released its earnings data on Wednesday, July 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.02. Analysts expect that EnteroMedics will post $-0.46 EPS for the current fiscal year.
Separately, analysts at Canaccord Genuity set a $3.00 price target on shares of EnteroMedics in a research note to investors on Tuesday, October 8th. They now have a buy rating on the stock.
EnteroMedics Inc (NASDAQ:ETRM) is a development- stage medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.